News

Between January and March 2019, Russia imported 2.6 bln RUB worth of pharmaceuticals made in the EEU countries (wholesale prices, VAT included), which is in monetary terms 49.6% higher than that of the same period in 2018. The dynamics in physical terms are +61.2% (65.3 mln units).

Between January and March 2019, Russia produced 86.9 bln RUB worth of pharmaceuticals (manufactures’ dispatch prices, VAT included), which is in monetary terms 14.7% higher than that of the same period of 2018. However, the dynamics in physical terms are only +0.5% (1.01 bln units).

In January 2019, Russia exported 1.53 bln RUB worth of pharmaceutical drugs (customs duties included, exports to the EEU countries excluded), which is in monetary terms 73.3% higher than that of January 2018. In physical terms, the dynamics are +46.4% (31.0 mln units.)

Between January and February 2019, Russia imported 9.0 bln RUB worth of veterinary products (free circulation prices, VAT included), which is in monetary terms 8.6% higher than that of the same period in 2018. Russia imported nearly 5.0 bln RUB of feed supplements (+6.4% in monetary terms), 3.7 bln RUB of veterinary drugs (+12.5%), and 0.36 bln RUB of veterinary APIs (+1.6%.)

Between January and February 2019, Russia imported 18.9 bln RUB worth of APIs (free circulation prices, VAT included), which is in monetary terms 26% higher than that of the same period in 2018. In physical terms, the dynamics are -7.5% (1.6 tons of APIs.)

Between January and February 2019, Russia imported 9.0 bln RUB worth of veterinary products (free circulation prices, VAT included), which is in monetary terms 8.6% higher than that of the same period in 2018. Russia imported nearly 5.0 bln RUB of feed supplements (+6.4% in monetary terms), 3.7 bln RUB of veterinary drugs (+12.5%), and 0.36 bln RUB of veterinary APIs (+1.6%.)

Between January and February 2019, Russia produced 53.6 bln RUB worth of pharmaceuticals (dispatch prices, VAT included), which is in monetary terms 14.3% higher than that of the same period in 2018. In physical terms, the dynamics are -1.5%, with 651.5 mln units.

Between January and February 2019, Russia imported nearly 1.7 bln RUB worth of pharmaceuticals made in the EEU countries (wholesale prices, VAT included), which is in monetary terms 74.3% higher than that of the same period in 2018. In physical terms, the dynamics are +85.8%, with 42.2 mln units.

In 2018, Russia exported 26.1 bln RUB worth of pharmaceuticals drugs (customs duties included, exports to the EEU countries excluded), which is in monetary terms 19.3% higher than that in 2017 – the highest dynamics in the past 3 years. The dynamics in physical terms are -11.9%, with 520.1 mln units of pharmaceuticals.

Despite the relatively modest results of the Russian pharmaceutical market in 2018, most large and medium-sized Russian wholesalers did not have anything to complain about. A number of distributors showed significant development dynamics. The so-called “second echelon” companies showed nearly exceptional results, with several companies having double-digit dispatch growth rates.